...
首页> 外文期刊>Nepal Journal of Epidemiology >Hepatic Steatosis and Diabetes Mellitus: Risk Factors, Pathophysiology and with its Clinical Implications: A Hospital Based Case Control Study in Western Region of Nepal
【24h】

Hepatic Steatosis and Diabetes Mellitus: Risk Factors, Pathophysiology and with its Clinical Implications: A Hospital Based Case Control Study in Western Region of Nepal

机译:肝脂肪变性和糖尿病:危险因素,病理生理学及其临床意义:尼泊尔西部地区基于医院的病例对照研究

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Background: The perception of nonalcoholic fatty liver disease (NAFLD) as an infrequent and benign condition is swiftly altering in developing countries as there has been an upsurge in non alcoholic fatty liver disease in Asia-Pacific region. NAFLD develops across all age groups and societies and is recognized to occur in 14%–30% of the common population. The foremost risk factors for NAFLD such as central obesity, diabetes mellitus, insulin resistance, dyslipidemia, hypertension, hypertriglyceridemia are currently predominant and puts a very large population at risk of evolving hepatic steatosis in the coming decades . Material and Methods: It was a hospital based case control study carried out in the Department of Biochemistry of Manipal Teaching Hospital, Pokhara, Nepal between 1 st January 2010 and 31 st Dec 2010. The variables collected were age, gender, fasting blood glucose, total cholesterol, low density lipoproteins, triglycerides, high density lipoproteins, very low density lipoproteins, aspartate transaminase, alanine transaminase . Results: Of the 200 patients of non alcoholic fatty liver disease patients with diabetes mellitus, all the variables except triglycerides shows insignificant disparity in relation to gender. The perceptible difference was observed in mean values of triglycerides for cases of NALFD between diabetes (218.25 ± SD 73.68) and non diabetic subjects (177.54 ± SD73.45) (p=.0001). The mean values of HDL did not illustrate much difference in cases of NALFD with diabetes (41.54 ± SD2.13) and non diabetic subjects (44.24 ± SD2.05). Conclusion: Public health initiatives are undoubtedly of the essence to halt or turn around the global 'diabesity' pandemic, the causal basis of NAFLD. Management of patients with NAFLD should be aimed at treating metabolic risk factors such as hyperglycemia and hypertriglyceridemia . Successful lifestyle adaptation with increased exercise and decreased food intake is able to remove the accumulation of liver fat and can reverse insulin resistance. Key words: Hepatic steatosis; Diabetes mellitus; Risk factors; Nepal. DOI: http://dx.doi.org/10.3126je.v1i2.5135 Nepal Journal of Epidemiology 2011;1 (2):51-56
机译:背景:由于亚太地区非酒精性脂肪肝疾病的兴起,发展中国家对非酒精性脂肪肝疾病(NAFLD)的发病率和良性状况的认识正在迅速改变。 NAFLD在所有年龄段和社会中都有发展,并且公认在14%–30%的普通人群中发生。目前,NAFLD的最主要危险因素是中枢性肥胖,糖尿病,胰岛素抵抗,血脂异常,高血压,高甘油三酯血症,并且在未来几十年内,很大一部分人群面临发展为肝脂肪变性的风险。材料与方法:这是一项基于医院的病例对照研究,于2010年1月1日至2010年12月31日在尼泊尔博克拉的Manipal教学医院生物化学系进行。所收集的变量包括年龄,性别,空腹血糖,总胆固醇,低密度脂蛋白,甘油三酸酯,高密度脂蛋白,极低密度脂蛋白,天冬氨酸转氨酶,丙氨酸转氨酶。结果:在200例非酒精性脂肪肝合并糖尿病的患者中,除甘油三酸酯外,所有变量在性别方面均无显着差异。观察到在糖尿病(218.25±SD 73.68)和非糖尿病受试者(177.54±SD73.45)之间,NALFD患者的甘油三酸酯平均值存在明显差异(p = .0001)。在患有糖尿病的NALFD(41.54±SD2.13)和非糖尿病受试者(44.24±SD2.05)的情况下,HDL的平均值无太大差异。结论:毫无疑问,公共卫生举措对于制止或扭转全球“糖尿病”流行病(NAFLD的因果关系)至关重要。 NAFLD患者的治疗应针对代谢危险因素,如高血糖和高甘油三酸酯血症。通过增加运动量和减少食物摄入量来成功地适应生活方式,能够消除肝脏脂肪的积聚并可以逆转胰岛素抵抗。关键词:肝脂肪变性糖尿病;风险因素;尼泊尔DOI:http://dx.doi.org/10.3126je.v1i2.5135尼泊尔流行病学杂志2011; 1(2):51-56

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号